A prominent pharmaceutical-industry executive based in Alpine, NJ, John Klein serves as the chairman of Cambridge Therapeutics. Previously named on Forbes’ list of the Top 100 CEOs, Cambridge Therapeutics’ John Klein has also led the Alpine, NJ-based business-consulting firm Bilogix since 2015.
An enterprise performance management (EPM) firm, Bilogix aims to serve as a strategic partner to businesses that wish to improve their future outlook in the midst of a rapidly-changing technological landscape. With more enterprises investing in digital solutions for everything from data storage and sales reports to customer relationship management, EPM consultants can help ensure an organization has a well-thought-out strategy for digital transformation.
Industry professionals advise chief executive officers to not hesitate too long before looking into EPM-driven technology solutions. A study by SAP and Oxford Economics found that 80 percent of companies had a rise in profitability after they completed a digital transformation. Those that fail to craft innovative business models and a comprehensive technological strategy that includes steps for integrating sales with the internet of things (IoT) will be left behind by their competition. However, trained EPM consultants can help companies ensure outstanding customer experiences as they continue to add increased technological capability.
An accomplished pharmaceutical industry executive, John Klein serves as the chairman of Cambridge Therapeutics in Alpine, NJ. In addition to directing the business development of Cambridge Therapeutics, John Klein recently founded a new venture in the emerging field of enterprise performance management (EPM).
Based in Alpine, NJ, the newest company is called Bilogix. A provider of strategic consulting services to a range of companies and organizations, Bilogix draws on the business-development and technological expertise of its team to help enterprises enhance their information technology (IT) infrastructure and achieve maximum operational efficiency.
The highly complex field of EPM encompasses many aspects, such as visualization of business strategy and metrics using tools such as strategy maps and performance dashboards. In the area of budgeting, EPM authorities use a range of resources to support financial analysis and decision-making, including cost and profitability modeling tools and improved management reporting systems. Another overarching EPM-solution approach is the integrated performance management system, which gives executives the feedback they need to evolve as productive and effective professionals.
The chairman of Cambridge Therapeutics in Alpine, NJ, John Klein is an experienced executive in the pharmaceutical industry. In addition to providing strategic guidance to Cambridge Therapeutics, John Klein recently launched Bilogix, his newest business venture based in Alpine.
Bilogix is a firm focused on meeting the enterprise performance management (EPM) needs of today’s businesses. A form of business intelligence, EPM refers to the high-level analysis of a company’s performance with the goal of creating a strategic plan that is designed to optimize its overall performance. EPM can help an enterprise to increase its efficiency, streamline operations, and meet its performance and financial goals. In addition, EMP can enable a company to make better business decisions.
Also known as corporate performance management, EPM encompasses solutions such as benchmarking, analytics, scorecards, management dashboards, performance reporting, and budgeting and forecasting. The use of these techniques and tools can assist organizations seeking to improve their performance and ultimately boost profits.
Serving as the chairman of Cambridge Therapeutics in Alpine, NJ, John Klein has more than two decades of executive experience in the healthcare and pharmaceutical industries. In addition to leading Cambridge Therapeutics, John Klein recently founded a new firm in Alpine, NJ, called Bilogix.
A company that provides enterprise performance management (EPM) services, Bilogix helps business clients attain maximum efficiency and boost profits. Using a complex approach to operations analysis, the EPM team reviews details such as budgets, sales forecasts and reports, and accounting information to determine ways in which a firm can enhance its performance and eliminate the waste of resources. The goal of EPM is to ensure that businesses have the data and knowledge they need to make optimal operational decisions that promote continued growth and long-term sustainability.
A large part of the EPM analysis deals with a company’s technological capacity. As cloud computing becomes more pervasive, smart institution leaders are adopting this and other advanced technologies to increase their flexibility and stay relevant.
Healthcare industry executive John Klein serves as the chairman of Cambridge Therapeutics in Alpine, NJ. In his supervisory role at Cambridge Therapeutics, John Klein sets the strategic direction for the company and remains familiar with new political and community developments affecting healthcare.
A new initiative that promotes the addition of affordable housing in the neighborhoods around New Jersey hospitals has received more funding and support than previously expected.
The executive director of the New Jersey Housing and Mortgage Finance Agency (HMFA), Charles Richman, originally announced that the project would receive $12 million from the organization. However, hospitals are matching the capital awarded by the HMFA, thus boosting the total to a minimum of $48 million. On top of that, Richman believed the state would fund only three or four alliances with medical facilities. However, at least six hospital-housing partnerships will be established by 2020, and the HMFA is hopeful this amount will increase to eight.
The first venture backed by this initiative is being completed on a vacant lot in Paterson. Resulting from a partnership between the HMFA and St. Joseph’s University Medical Center, the project is a 70-unit development that will feature one- to three-bedroom apartments. These units will largely be reserved for low-income residents, many of whom can benefit from hospital services.